Lianfeng HUANG

Person

Basking Ridge, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Solid forms comprising an oxime ether compound and a coformer, comp...
- Patent number 12,049,446
- Issue date Jul 30, 2024
- Novartis AG
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid forms comprising an oxime ether compound, compositions and me...
- Patent number 11,958,805
- Issue date Apr 16, 2024
- Novartis AG
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-...
- Patent number 11,701,362
- Issue date Jul 18, 2023
- Celgene Corporation
- Scott Bone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromet...
- Patent number 11,680,046
- Issue date Jun 20, 2023
- Celgene Corporation
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Forms and compositions of a MK2 inhibitor
- Patent number 11,629,153
- Issue date Apr 18, 2023
- Celgene CAR LLC
- Jianxin Han
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid forms comprising an oxime ether compound, compositions and me...
- Patent number 11,629,124
- Issue date Apr 18, 2023
- Novartis AG
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid forms comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro...
- Patent number 11,578,056
- Issue date Feb 14, 2023
- Celgene Corporation
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid forms comprising an oxime ether compound and a coformer, comp...
- Patent number 11,434,200
- Issue date Sep 6, 2022
- Novartis AG
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid forms comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1...
- Patent number 11,370,777
- Issue date Jun 28, 2022
- Celgene Corporation
- Gerald D. Artman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Salts of a thiazolidinone compound, solid forms, compositions and m...
- Patent number 11,186,556
- Issue date Nov 30, 2021
- Celgene Corporation
- Lianfeng Huang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromet...
- Patent number 11,053,199
- Issue date Jul 6, 2021
- Celgene Corporation
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid forms of a thiazolidinone compound, compositions and methods...
- Patent number 11,013,723
- Issue date May 25, 2021
- Celgene Corporation
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid forms comprising a thiazolidinone compound, compositions and...
- Patent number 11,014,897
- Issue date May 25, 2021
- Celgene Corporation
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-...
- Patent number 10,898,488
- Issue date Jan 26, 2021
- Celgene Corporation
- Scott Bone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Forms and compositions of a MK2 inhibitor
- Patent number 10,882,867
- Issue date Jan 5, 2021
- Celgene CAR LLC
- Jianxin Han
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods of use of cis-4-[2-{[3S,4R)-3-fluorooxan-4...
- Patent number 10,653,697
- Issue date May 19, 2020
- Celgene Corporation
- Scott Bone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methy...
- Patent number 10,590,089
- Issue date Mar 17, 2020
- Signal Pharmaceuticals, LLC
- Nathan Andrew Boersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-...
- Patent number 10,543,214
- Issue date Jan 28, 2020
- Celgene Corporation
- Scott Bone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid forms of (1S,4S)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4...
- Patent number 10,513,519
- Issue date Dec 24, 2019
- Signal Pharmaceuticals, LLC
- Zheng Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Forms and compositions of an ERK inhibitor
- Patent number 10,202,364
- Issue date Feb 12, 2019
- Celgene CAR LLC
- Antonio Christian Ferretti
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4methyl...
- Patent number 10,131,639
- Issue date Nov 20, 2018
- Signal Pharmaceuticals, LLC
- Nathan Andrew Boersen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Solid forms of (1S,4S)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4...
- Patent number 10,047,090
- Issue date Aug 14, 2018
- Signal Pharmaceuticals, LLC
- Zheng Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Forms and compositions of an ERK inhibitor
- Patent number 10,005,760
- Issue date Jun 26, 2018
- Celgene CAR LLC
- Antonio Christian Ferretti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methyl...
- Patent number 9,814,713
- Issue date Nov 14, 2017
- Signal Pharmaceuticals, LLC
- Hon-Wah Man
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Romidepsin formulations and uses thereof
- Patent number 9,795,650
- Issue date Oct 24, 2017
- Celgene Corporation
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-Methy...
- Patent number 9,796,685
- Issue date Oct 24, 2017
- Signal Pharmaceuticals, LLC
- Nathan Andrew Boersen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Romidepsin formulations and uses thereof
- Patent number 9,782,451
- Issue date Oct 10, 2017
- Celgene Corporation
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Romidepsin formulations and uses thereof
- Patent number 9,468,664
- Issue date Oct 18, 2016
- Celgene Corporation
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Romidepsin formulations and uses thereof
- Patent number 9,463,215
- Issue date Oct 11, 2016
- Celgene Corporation
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methyl...
- Patent number 9,365,524
- Issue date Jun 14, 2016
- Signal Pharmaceuticals, LLC
- Hon-Wah Man
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CRYSTALLINE (R)-5-CARBAMOYLPYRIDIN-3-YL-2-METHYL-4-(3-(TRIFLUOROMET...
- Publication number 20230382861
- Publication date Nov 30, 2023
- Celgene Corporation
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID FORMS COMPRISING (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO...
- Publication number 20230339901
- Publication date Oct 26, 2023
- Celgene Corporation
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID FORMS COMPRISING AN OXIME ETHER COMPOUND, COMPOSITIONS AND ME...
- Publication number 20230219887
- Publication date Jul 13, 2023
- Novartis AG
- Lianfeng HUANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID FORMS COMPRISING AN OXIME ETHER COMPOUND AND A COFORMER, COMP...
- Publication number 20230015251
- Publication date Jan 19, 2023
- Novartis AG
- Lianfeng Huang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID FORMS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1...
- Publication number 20220289713
- Publication date Sep 15, 2022
- Celgene Corporation
- Gerald D. Artman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE (R)-5-CARBAMOYLPYRIDIN-3-YL-2-METHYL-4-(3-(TRIFLUOROMET...
- Publication number 20210363105
- Publication date Nov 25, 2021
- Celgene Corporation
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMS AND COMPOSITIONS OF A MK2 INHIBITOR
- Publication number 20210198276
- Publication date Jul 1, 2021
- Celgene CAR LLC
- Jianxin Han
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Solid Forms Comprising an Oxime Ether Compound and a Coformer, Comp...
- Publication number 20210139420
- Publication date May 13, 2021
- Novartis AG
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS OF USE OF CIS-4-[2-{[(3S,4R)-3-FLUOROOXAN-...
- Publication number 20210128564
- Publication date May 6, 2021
- Celgene Corporation
- Scott Bone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID FORMS COMPRISING (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO...
- Publication number 20210115019
- Publication date Apr 22, 2021
- Celgene Corporation
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Solid Forms Comprising an Oxime Ether Compound, Compositions and Me...
- Publication number 20200399213
- Publication date Dec 24, 2020
- Novartis AG
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Solid Forms Comprising An Oxime Ether Compound, Compositions and Me...
- Publication number 20200377454
- Publication date Dec 3, 2020
- Novartis AG
- Lianfeng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS OF USE OF CIS-4-[2-{[(3S,4R)-3-FLUOROOXAN-...
- Publication number 20200237767
- Publication date Jul 30, 2020
- Celgene Corporation
- Scott Bone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID FORMS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1...
- Publication number 20200216418
- Publication date Jul 9, 2020
- Celgene Corporation
- Gerald D. Artman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FORMS AND COMPOSITIONS OF A MK2 INHIBITOR
- Publication number 20200148701
- Publication date May 14, 2020
- Celgene CAR LLC
- Jianxin Han
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS OF USE OF CIS-4-[2-{[(3S,4R)-3-FLUOROOXAN-...
- Publication number 20200113908
- Publication date Apr 16, 2020
- Celgene Corporation
- Scott Bone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE (R)-5-CARBAMOYLPYRIDIN-3-YL-2-METHYL-4-(3-(TRIFLUOROMET...
- Publication number 20200095201
- Publication date Mar 26, 2020
- Celgene Corporation
- Lianfeng Huang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS OF USE OF CIS-4-[2-{[(3S,4R)-3-FLUOROOXAN-...
- Publication number 20190099425
- Publication date Apr 4, 2019
- Celgene Corporation
- Scott Bone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATIONS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHY...
- Publication number 20190031619
- Publication date Jan 31, 2019
- Signal Pharmaceuticals, LLC.
- Nathan Andrew BOERSEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID FORMS OF (1S,4S)-4-(2-(((3S,4R)-3-FLUOROTETRAHYDRO-2H-PYRAN-4...
- Publication number 20180362529
- Publication date Dec 20, 2018
- Signal Pharmaceuticals, LLC.
- Zheng Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FORMS AND COMPOSITIONS OF AN ERK INHIBITOR
- Publication number 20180362498
- Publication date Dec 20, 2018
- Celgene CAR LLC
- Antonio Christian Ferretti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID FORMS OF 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPERI...
- Publication number 20180258064
- Publication date Sep 13, 2018
- Celgene Corporation
- Lianfeng Huang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FORMULATIONS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHY...
- Publication number 20180009765
- Publication date Jan 11, 2018
- Signal Pharmaceuticals, LLC.
- Nathan Andrew BOERSEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID FORMS OF (1S,4S)-4-(2-(((3S,4R)-3-FLUOROTETRAHYDRO-2H-PYRAN-4...
- Publication number 20170283418
- Publication date Oct 5, 2017
- Signal Pharmaceuticals, LLC.
- Zheng Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FORMS AND COMPOSITIONS OF AN ERK INHIBITOR
- Publication number 20170226083
- Publication date Aug 10, 2017
- Celgene CAR LLC
- Antonio Christian Ferretti
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ROMIDEPSIN FORMULATIONS AND USES THEREOF
- Publication number 20170007665
- Publication date Jan 12, 2017
- Celgene Corporation
- Lianfeng HUANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ROMIDEPSIN FORMULATIONS AND USES THEREOF
- Publication number 20170000845
- Publication date Jan 5, 2017
- Celgene Corporation
- Lianfeng HUANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ROMIDEPSIN FORMULATIONS AND USES THEREOF
- Publication number 20160367625
- Publication date Dec 22, 2016
- Celgene Corporation
- Lianfeng HUANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID FORMS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYL...
- Publication number 20160256459
- Publication date Sep 8, 2016
- Signal Pharmaceuticals, LLC.
- Hon-Wah Man
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATIONS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHY...
- Publication number 20160168105
- Publication date Jun 16, 2016
- Signal Pharmaceuticals, LLC.
- Nathan Andrew BOERSEN
- C07 - ORGANIC CHEMISTRY

Lianfeng HUANG

Person

Patents Grantslast 30 patents

Solid forms comprising an oxime ether compound and a coformer, comp...

Solid forms comprising an oxime ether compound, compositions and me...

Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-...

Crystalline (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromet...

Forms and compositions of a MK2 inhibitor

Solid forms comprising an oxime ether compound, compositions and me...

Solid forms comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro...

Solid forms comprising an oxime ether compound and a coformer, comp...

Solid forms comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1...

Salts of a thiazolidinone compound, solid forms, compositions and m...

Crystalline (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromet...

Solid forms of a thiazolidinone compound, compositions and methods...

Solid forms comprising a thiazolidinone compound, compositions and...

Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-...

Forms and compositions of a MK2 inhibitor

Compositions and methods of use of cis-4-[2-{[3S,4R)-3-fluorooxan-4...

Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methy...

Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-...

Solid forms of (1S,4S)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4...

Forms and compositions of an ERK inhibitor

Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4methyl...

Solid forms of (1S,4S)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4...

Forms and compositions of an ERK inhibitor

Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methyl...

Romidepsin formulations and uses thereof

Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-Methy...

Romidepsin formulations and uses thereof

Romidepsin formulations and uses thereof

Romidepsin formulations and uses thereof

Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methyl...

Patents Applicationslast 30 patents

CRYSTALLINE (R)-5-CARBAMOYLPYRIDIN-3-YL-2-METHYL-4-(3-(TRIFLUOROMET...

SOLID FORMS COMPRISING (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO...

SOLID FORMS COMPRISING AN OXIME ETHER COMPOUND, COMPOSITIONS AND ME...

SOLID FORMS COMPRISING AN OXIME ETHER COMPOUND AND A COFORMER, COMP...

SOLID FORMS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1...

CRYSTALLINE (R)-5-CARBAMOYLPYRIDIN-3-YL-2-METHYL-4-(3-(TRIFLUOROMET...

FORMS AND COMPOSITIONS OF A MK2 INHIBITOR

Solid Forms Comprising an Oxime Ether Compound and a Coformer, Comp...

COMPOSITIONS AND METHODS OF USE OF CIS-4-[2-{[(3S,4R)-3-FLUOROOXAN-...

SOLID FORMS COMPRISING (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO...

Solid Forms Comprising an Oxime Ether Compound, Compositions and Me...

Solid Forms Comprising An Oxime Ether Compound, Compositions and Me...

COMPOSITIONS AND METHODS OF USE OF CIS-4-[2-{[(3S,4R)-3-FLUOROOXAN-...

SOLID FORMS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1...

FORMS AND COMPOSITIONS OF A MK2 INHIBITOR

COMPOSITIONS AND METHODS OF USE OF CIS-4-[2-{[(3S,4R)-3-FLUOROOXAN-...

CRYSTALLINE (R)-5-CARBAMOYLPYRIDIN-3-YL-2-METHYL-4-(3-(TRIFLUOROMET...

COMPOSITIONS AND METHODS OF USE OF CIS-4-[2-{[(3S,4R)-3-FLUOROOXAN-...

FORMULATIONS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHY...

SOLID FORMS OF (1S,4S)-4-(2-(((3S,4R)-3-FLUOROTETRAHYDRO-2H-PYRAN-4...

FORMS AND COMPOSITIONS OF AN ERK INHIBITOR

SOLID FORMS OF 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPERI...

FORMULATIONS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHY...

SOLID FORMS OF (1S,4S)-4-(2-(((3S,4R)-3-FLUOROTETRAHYDRO-2H-PYRAN-4...

FORMS AND COMPOSITIONS OF AN ERK INHIBITOR

ROMIDEPSIN FORMULATIONS AND USES THEREOF

ROMIDEPSIN FORMULATIONS AND USES THEREOF

ROMIDEPSIN FORMULATIONS AND USES THEREOF

SOLID FORMS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYL...

FORMULATIONS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHY...